Rob will begin his remarks with an update on our business, review our performance against our 2025 priorities, and lay out our 2026 objectives. Then Mark will review the fourth quarter results and ...

Bioventus develops musculoskeletal therapies including biologics and nerve stimulation systems. Discover company developments ...

Q4 reported revenue of $157.9 million increased 2.8% and organic* revenue increased 10.0% Fourth quarter GAAP earnings of $0.21 per diluted share ...

Bioventus Inc (BVS) reports a robust quarter with 10% organic revenue growth, expanded EBITDA margins, and strategic advancements in growth drivers like PNS and PRP.

In a deal nearly two years in the making, Bioventus has opted to acquire fellow orthopedic devicemaker CartiHeal—less than a week after CartiHeal announced its flagship cartilage repair implant ...

Investing.com -- Shares of Bioventus (NASDAQ:BVS) climbed 7.58% to $9.11 in premarket trading on Thursday after the medical device maker reported fourth-quarter results that exceeded Wall Street ...

After going public with a $100 million initial public offering earlier this year, Bioventus has now made its largest-ever acquisition. The Durham biotechnology company, which makes treatments for knee ...

Barely a month after the plan was unveiled, Bioventus’ acquisition of fellow orthopedic devicemaker CartiHeal appears to be on much shakier ground. Bioventus has walked away from an offering of senior ...

Detailed price information for Bioventus Inc Cl A (BVS-Q) from The Globe and Mail including charting and trades.

Bioventus recently announced that its shareholders approved its agreement to acquire Misonix. Bioventus agrees to pay Misonix shareholders either 1.6839 shares of Bioventus class A common stock or $28 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Bioventus announced its first-quarter 2024 financial ...

The medical technology company Bioventus jumped deeper into biotech’s tumultuous waters on Thursday by registering a $150 million initial public stock offering. Headquartered in Durham, North Carolina ...